Advancing sustainability through digitalization: from drug development to patient care

Remo Eugster; Paola Luciani

doi:10.1039/d5pm00342c

January 1, 2026RSC PharmaceuticsOpen Access

Advancing sustainability through digitalization: from drug development to patient care

View Full Paper

Ask AI

Bookmark

Share

Key Points

The research aims to explore how digitalization enhances sustainability in the pharmaceutical sector.
Reviewed existing literature on digital tools and sustainability in pharmaceuticals.
Analyzed case studies of digital innovations in drug discovery and patient care.
Evaluated the impact of digitalization on the pharmaceutical value chain.
Identified key digital tools that improve drug development efficiencies.
Found significant reduction in resource waste across the value chain.
Demonstrated enhanced patient engagement through digital health platforms.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Digitalization improves sustainability in drug development and patient care, suggesting a transformation in the pharmaceutical industry.

Abstract

Digitalization is transforming the pharmaceutical industry, offering innovative solutions to enhance sustainability across the pharmaceutical value chain. From drug discovery to patient care, digital tools such as artificial intelligence (AI),...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Eugster et al. (2026) studied this question.

synapsesocial.com/papers/69994cc2873532290d021788 https://doi.org/10.1039/d5pm00342c

View Full Paper

Ask AI

Bookmark

Share

Advancing sustainability through digitalization: from drug development to patient care

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Advancing sustainability through digitalization: from drug development to patient care

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading